Local or distant relapse is the key event for the overall survival of early-stage breast cancer after initial surgery. A small subset of breast cancer cells, which share similar properties with normal stem cells, has been proven to resist to clinical therapy contributing to recurrence. | A multiple breast cancer stem cell model to predict recurrence of T1 3 N0 breast cancer